國家衛生研究院 NHRI:Item 3990099045/15372
English  |  正體中文  |  简体中文  |  全文筆數/總筆數 : 12145/12927 (94%)
造訪人次 : 910104      線上人數 : 807
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 查詢小技巧：
  • 您可在西文檢索詞彙前後加上"雙引號"，以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋，建議至進階搜尋限定作者欄位，可獲得較完整資料
    •  進階搜尋
    主頁 ‧ 登入 ‧ 上傳 ‧ 說明 ‧ 關於NHRI ‧ 管理 到手機版


    請使用永久網址來引用或連結此文件: http://ir.nhri.org.tw/handle/3990099045/15372


    題名: Biomarkers as potential indicators for substance use disorder patient care
    作者: Liu, YL
    貢獻者: Center for Neuropsychiatric Research
    摘要: Introduction: Current diagnosis for substance use disorder is primarily using sensitive chromatographic system to measure the blood levels of substances, such as ketamine, mephedrone. As many substances use disorder (SUD) patients use more than one substance, the current measure methods may sometimes overlook all substances. Methods: In our previous studies, several plasma protein indicators have shown a potential for assistance in consequences for substance use disorder patients. These indicators have been reported with different levels of elevation in heroin [1], ketamine [2], and alcohol dependent [3] patients. These indicators may also lead to understanding the severity of tissue damages or progress of addictions. Results: At least three plasma protein indicators within our studies showed potential for assistance in monitoring the progress of addictions as follows: Nectin-4 which may indicate continued use of ketamine or opioids; the C-C motif chemokine ligand 11 (CCL11) is an indicator of the inflammatory chronic stress including the brain; and the neurofilament light chain may indicate neuronal toxicity after chronic substance use. Conclusions: Patient-centered care is essential for substance use disorder patients. Until now, there has not been focused on these peripheral blood plasma indicators and their applications for these patients. Because the high correlations between the plasma protein indicators and the substances patients continue using, we proposed to apply the objective indictors to assist monitoring the progress of substance use disorder patients.
    日期: 2023-07
    關聯: British Journal of Pharmacology. 2023 Jul;180(Suppl. 1):273-273.
    Link to: http://dx.doi.org/10.1111/bph.16106
    JIF/Ranking 2023: http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=0007-1188&DestApp=IC2JCR
    Cited Times(WOS): https://www.webofscience.com/wos/woscc/full-record/WOS:001043027400209
    顯示於類別:[劉玉麗] 會議論文/會議摘要

    文件中的檔案:

    檔案 描述 大小格式瀏覽次數
    ISI001043027400209.pdf179KbAdobe PDF37檢視/開啟


    在NHRI中所有的資料項目都受到原著作權保護.

    TAIR相關文章

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回饋